Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1018149]Researchers: Dr Kate Mahon (Principal investigator)
Brief description Prostate cancer is the most common cancer in Australian men. Chemotherapy is used in advanced disease, but is only effective in ~50% of patients. In the first year of my PhD, I identified 8 plasma biomarkers that predict chemotherapy resistance. I plan to characterise how these immune molecules cause chemotherapy resistance using a mouse model of advanced prostate cancer. These markers may allow us to personalise prostate cancer treatment in the future and identify more effective therapies.
Funding Amount $AUD 74,365.00
Funding Scheme NHMRC Postgraduate Scholarships
Notes Medical Postgraduate Scholarship
- nhmrc : 1018149
- PURL : https://purl.org/au-research/grants/nhmrc/1018149
